Nautilus Biotechnolgy (NAUT) Earnings Date & Reports
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NAUT is expected to report earnings to rise 10.77% to -14 cents per share on August 05
Q2'25
Est.
$-0.14
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.02
The last earnings report on April 29 showed earnings per share of -12 cents, beating the estimate of -15 cents. With 43.83K shares outstanding, the current market capitalization sits at 90.13M.